APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: The apoA-I and CIGB-258 mixture were administrated to zebrafish embryos and adults to evaluate in vivo anti-inflammatory activities in the presence of CML, which can cause acute embryotoxicity, developmental defects, and acute paralysis and inflammatory death.